Coeliac disease

Lancet

Volumn 362, Issue 9381, 2003, Pages 383-391

  Green, Peter H R ^a   Jabri, Bana ^b  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTEN;

AUTOIMMUNE DISEASE; CARCINOMA; CELIAC DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; GENETICS; HISTOPATHOLOGY; HLA TYPING; HUMAN; IMMUNE RESPONSE; LAMINA PROPRIA; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; SEROLOGY;

EID: 0041669320     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14027-5     Document Type: Conference Paper

References (142)

1. Kasarda DD. Gluten and gliadin: precipitating factors in coeliac disease. In: Maki M, Collin P, Visakopi JK, eds. Proceedings of the 7th International Symposium on Coeliac Disease, 1996: 195-212.
2. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology. 102:1992;330-354.
3. Sollid L.M. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2:2002;647-655.
4. Green P.H., Shane E., Rotterdam H., Forde K.A., Grossbard L. Significance of unsuspected celiac disease detected at endoscopy. Gastrointest Endosc. 51:2000;60-65.
5. Tursi A., Giorgetti G., Brandimarte G., Rubino E., Lombardi D., Gasbarrini G. Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology. 48:2001;462-464.
6. Kaukinen K., Halme L., Collin P., et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology. 122:2002;881-888.
7. Logan R.F., Rifkind E.A., Turner I.D., Ferguson A. Mortality in celiac disease. Gastroenterology. 97:1989;265-271.
8. Cottone M., Termini A., Oliva L., et al. Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci. 44:1999;2538-2541.
9. Corrao G., Corazza G.R., Bagnardi V., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 358:2001;356-361.
10. Collin P., Reunala T., Pukkala E., Laippala P., Keyrilainen O., Pasternack A. Coeliac disease-associated disorders and survival. Gut. 35:1994;1215-1218.
11. Bevan S., Popat S., Braegger C.P., et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet. 36:1999;687-690.
12. Greco L., Romino R., Coto I., et al. The first large population based twin study of coeliac disease. Gut. 50:2002;624-628.
13. Greco L., Corazza G., Babron M.C., et al. Genome search in celiac disease. Am J Hum Genet. 62:1998;669-675.
14. Liu J., Juo S.H., Holopainen P., et al. Genomewide linkage analysis of celiac disease in Finnish families. Am J Hum Genet. 70:2002;51-59.
15. Naluai A.T., Nilsson S., Gudjonsdottir A.H., et al. Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11. Eur J Hum Genet. 9:2001;938-944.
16. Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 120:2001;636-651.
17. Catassi C., Fabiani E., Ratsch I.M., et al. The coeliac iceberg in Italy: a multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl. 412:1996;29-35.
18. Gandolfi L., Pratesi R., Cordoba J.C., Tauil P.L., Gasparin M., Catassi C. Prevalence of celiac disease among blood donors in Brazil. Am J Gastroenterol. 95:2000;689-692.
19. Not T., Horvath K., Hill I.D., et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol. 33:1998;494-498.
20. Catassi C., Ratsch I.M., Gandolfi L., et al. Why is coeliac disease endemic in the people of the Sahara? Lancet. 354:1999;647-648.
21. Shahbazkhani B., Maghari M., Moghaddam S.N. Prevalence of celiac disease among Iranian patients with chronic diarrhea. J Pediatr Gastroenterol Nutr. 31:2000;54.
22. Sood A., Midha V., Sood N., Kaushal V., Puri H. Increasing incidence of celiac disease in India. Am J Gastroenterol. 96:2001;2804-2805.
23. Ivarsson A., Hernell O., Stenlund H., Persson L.A. Breast-feeding protects against celiac disease. Am J Clin Nutr. 75:2002;914-921.
24. Monteleone G., Pender S.L., Wathen N.C., MacDonald T.T. Interferon-alpha drives T cell-mediated immunopathology in the intestine. Eur J Immunol. 31:2001;2247-2255.
25. Vazquez H., Smecuol E., Flores D., et al. Relation between cigarette smoking and celiac disease: evidence from a case-control study. Am J Gastroenterol. 96:2001;798-802.
26. Rubin C.E. Some reflections on reversibility, gluten and the intestine. Gastroenterology. 39:1960;260-261.
27. Schweizer J.J., Oren A., Mearin M.L. Cancer in children with celiac disease: a survey of the european society of paediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 33:2001;97-100.
28. Campbell C.B., Roberts R.K., Cowen A.E. The changing clinical presentation of coeliac disease in adults. Med J Aust. 1:1977;89-93.
29. Logan R.F., Tucker G., Rifkind E.A., Heading R.C., Ferguson A. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. BMJ (Clin Res Ed). 286:1983;95-97.
30. Green P.H.R., Stavropoulos S.N., Panagi S.G., et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 96:2001;126-131.
31. Lankisch P.G., Martinez Schramm A., Petersen F., Droge M., Lehnick D., Lembcke B. Diagnostic intervals for recognizing celiac disease. Z Gastroenterol. 34:1996;473-477.
32. Sanders D.S., Carter M.J., Hurlstone D.P., et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet. 358:2001;1504-1508.
33. Collin P., Reunala T., Rasmussen M., et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol. 32:1997;1129-1133.
34. Lo W., Sano K., Lebwohl B., Diamond B., Green P.H.R. Changing presentation of celiac disease. Dig Dis Sci. 48:2003;395-398.
35. Niveloni S., Fiorini A., Dezi R., et al. Usefulness of videoduodenoscopy and vital dye staining as indicators of mucosal atrophy of celiac disease: assessment of interobserver agreement. Gastrointest Endosc. 47:1998;223-229.
36. Shah V.H., Rotterdam H., Kotler D.P., Fasano A., Green P.H. All that scallops is not celiac disease. Gastrointest Endosc. 51:2000;717-720.
37. Bodvarsson S., Jonsdottir I., Freysdottir J., Leonard J.N., Fry L., Valdimarsson T. Dermatitis herpetiformis: an autoimmune disease due to cross-reaction between dietary glutenin and dermal elastin. Scand J Immunol. 38:1993;546-550.
38. Leonard J.N., Tucker W.F., Fry J.S., et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ (Clin Res Ed). 286:1983;16-18.
39. Alaedini A., Green P.H., Sander H.W., et al. Ganglioside reactive antibodies in the neuropathy associated with celiac disease. J Neuroimmunol. 127:2002;145-148.
40. Hadjivassiliou M., Grunewald R.A., Chattopadhyay A.K., et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 352:1998;1582-1585.
41. Molteni N., Bardella M.T., Baldassarri A.R., Bianchi P.A. Celiac disease associated with epilepsy and intracranial calcifications: report of two patients. Am J Gastroenterol. 83:1988;992-994.
42. Lahteenoja H., Toivanen A., Viander M., et al. Oral mucosal changes in coeliac patients on a gluten-free diet. Eur J Oral Sci. 106:1998;899-906.
43. Lepore L., Martelossi S., Pennesi M., et al. Prevalence of celiac disease in patients with juvenile chronic arthritis. J Pediatr. 129:1996;311-313.
44. Aine L., Maki M., Collin P., Keyrilainen O. Dental enamel defects in celiac disease. J Oral Pathol Med. 19:1990;241-245.
45. Bardella M.T., Fraquelli M., Quatrini M., Molteni N., Bianchi P., Conte D. Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology. 22:1995;833-886.
46. Talal A.H., Murray J.A., Goeken J.A., Sivitz W.I. Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing. Am J Gastroenterol. 92:1997;1280-1284.
47. Gale L., Wimalaratna H., Brotodiharjo A., Duggan J.M. Down's syndrome is strongly associated with coeliac disease. Gut. 40:1997;492-496.
48. Dickey W., McMillan S.A. Co-screening for primary biliary cirrhosis and coeliac disease. Association between primary biliary cirrhosis and coeliac disease. Gut. 43:1998;300.
49. Revised criteria for diagnosis of coeliac disease. Arch Dis Child. 65:1990;909-911.
50. Lee S.K., Lo W., Memeo L., Rotterdam H., Green P.H. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc. 57:2003;187-191.
51. Association A.G. American Gastroenterological Association medical position statement: Celiac Sprue. Gastroenterology. 120:2001;1522-1525.
52. Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 3:1997;797-801.
53. Sulkanen S., Halttunen T., Laurila K., et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology. 115:1998;1322-1328.
54. Sblattero D., Berti I., Trevisiol C., et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol. 95:2000;1253-1257.
55. Kaukinen K., Partanen J., Maki M., Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol. 97:2002;695-699.
56. Cataldo F., Marino V., Ventura A., Bottaro G., Corazza G.R. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut. 42:1998;362-365.
57. Cataldo F., Lio D., Marino V., Picarelli A., Ventura A., Corazza G.R. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut. 47:2000;366-369.
58. Sategna-Guidetti C., Pulitano R., Grosso S., Ferfoglia G. Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol. 17:1993;123-127.
59. Tursi A., Brandimarte G., Giorgetti G., Gigliobianco A., Lombardi D., Gasbarrini G. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol. 96:2001;1507-1510.
60. Whelan A., Willoughby R., Weir D. Human umbilical vein endothelial cells: a new easily available source of endomysial antigens. Eur J Gastroenterol Hepatol. 8:1996;961-966.
61. Kumar V., Lerner A., Valeski J.E., Beutner E.H., Chorzelski T.P., Rossi T. Endomysial antibodies in the diagnosis of celiac disease and the effect of gluten on antibody titers. Immunol Invest. 18:1989;533-544.
62. Dieterich W., Laag E., Schopper H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 115:1998;1317-1321.
63. Dickey W., Hughes D.F., McMillan S.A. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol. 35:2000;181-183.
64. Rostami K., Kerckhaert J., Tiemessen R., von Blomberg B.M., Meijer J.W., Mulder C.J. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 94:1999;888-894.
65. Dahele A.V., Aldhous M.C., Humphreys K., Ghosh S. Serum IgA tissue transglutaminase antibodies in coeliac disease and other gastrointestinal diseases. QJM. 94:2001;195-205.
66. Dickey W., McMillan S.A., Hughes D.F. Sensitivity of serum tissue transglutaminase antibodies for endomysial antibody positive and negative coeliac disease. Scand J Gastroenterol. 36:2001;511-514.
67. Green P.H., Barry M., Matsutani M. Serologic tests for celiac disease. Gastroenterology. 124:2003;585-586.
68. Signorini M., Bortolotti F., Poltronieri L., Bergamini C.M. Human erythrocyte transglutaminase: purification and preliminary characterisation. Biol Chem Hoppe Seyler. 369:1988;275-281.
69. Carroccio A., Giannitrapani L., Soresi M., et al. Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease. Gut. 49:2001;506-511.
70. Leon F., Pena R., Camerero C., et al. Limitations of anti-guinea pig liver transglutaminase IgA in screening of celiac disease. Gastroenterology. 120:2001;586-587.
71. Murray J.A., Herlein J., Mitros F., Goeken J.A. Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study. Clin Diagn Lab Immunol. 7:2000;584-587.
72. Shidrawi R.G., Przemioslo R., Davies D.R., Tighe M.R., Ciclitira P.J. Pitfalls in diagnosing coeliac disease. J Clin Pathol. 47:1994;693-694.
73. Jensen K., Sollid L.M., Scott H., et al. Gliadin-specific T cell responses in peripheral blood of healthy individuals involve T cells restricted by the coeliac disease associated DQ2 heterodimer. Scand J Immunol. 42:1995;166-170.
74. Fasano A., Not T., Wang W., et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 355:2000;1518-1519.
75. Jabri B, Cellier C, Patey N, Schmitz J, Brousse N, Cerf-Bensussan N. Intraepithelial lymphocytes in coeliac disease. Proceedings of the Eighth International Symposium on Coeliac Disease. Naples, Italy, April 21-24, 1999.
76. van de Wal Y., Kooy Y., van Veelen P., et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol. 161:1998;1585-1588.
77. Molberg O., McAdam S.N., Korner R., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med. 4:1998;713-717.
78. Anderson R.P., Degano P., Godkin A.J., Jewell D.P., Hill A.V. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med. 6:2000;337-342.
79. Arentz-Hansen H., Korner R., Molberg O., et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 191:2000;603-612.
80. Shan L., Molberg O., Parrot I., et al. Structural basis for gluten intolerance in celiac sprue. Science. 297:2002;2275-2279.
81. Vader W., Kooy Y., Van Veelen P., et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology. 122:2002;1729-1737.
82. de Ritis G., Auricchio S., Jones H.W., Lew E.J., Bernardin J.E., Kasarda D.D. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology. 94:1988;41-49.
83. Maiuri L., Ciacci C., Raia V., et al. FAS engagement drives apoptosis of enterocytes of coeliac patients. Gut. 48:2001;418-424.
84. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA. 93:1996;12445-12450.
85. Roberts A.I., Lee L., Schwarz E., et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol. 167:2001;5527-5530.
86. Jabri B., de Serre N.P., Cellier C., et al. Selective expansion of intraepithelial lymphocytes expressing the HLA-E- specific natural killer receptor CD94 in celiac disease. Gastroenterology. 118:2000;867-879.
87. Braud V.M., Allan D.S., O'Callaghan C.A., et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
88. Fehniger T.A., Suzuki K., VanDeusen J.B., Cooper M.A., Freud A.G., Caligiuri M.A. Fatal leukemia in interleukin-15 transgenic mice. Blood Cells Mol Dis. 27:2001;223-230.
89. Janatuinen E.K., Kemppainen T.A., Julkunen R.J., et al. No harm from five year ingestion of oats in coeliac disease. Gut. 50:2002;332-335.
90. Hoffenberg E.J., Haas J., Drescher A., et al. A trial of oats in children with newly diagnosed celiac disease. J Pediatr. 137:2000;361-366.
91. Mustalahti K., Lohiniemi S., Collin P., Vuolteenaho N., Laippala P., Maki M. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract. 5:2002;105-113.
92. Kolsteren M.M., Koopman H.M., Schalekamp G., Mearin M.L. Health-related quality of life in children with celiac disease. J Pediatr. 138:2001;593-595.
93. Hallert C., Granno C., Grant C., et al. Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol. 33:1998;933-938.
94. Carroccio A., Iacono G., Montalto G., et al. Pancreatic enzyme therapy in childhood celiac disease: a double-blind prospective randomized study. Dig Dis Sci. 40:1995;2555-2560.
95. Fine K.D., Lee E.L., Meyer R.L. Colonic histopathology in untreated celiac sprue or refractory sprue: is it lymphocytic colitis or colonic lymphocytosis? Hum Pathol. 29:1998;1433-1440.
96. Corazza G.R., Biagi F., Volta U., Andreani M.L., De Franceschi L., Gasbarrini G. Autoimmune enteropathy and villous atrophy in adults. Lancet. 350:1997;106-109.
97. Ryan B.M., Kelleher D. Refractory celiac disease. Gastroenterology. 119:2000;243-251.
98. Cellier C., Patey N., Mauvieux L., et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology. 114:1998;471-481.
99. Patey-Mariaud De Serre N., Cellier C., Jabri B., et al. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology. 37:2000;70-77.
100. Vaidya A., Bolanos J., Berkelhammer C. Azathioprine in refractory sprue. Am J Gastroenterol. 94:1999;1967-1969.
101. Longstreth G.F. Successful treatment of refractory sprue with cyclosporine. Ann Intern Med. 119:1993;1014-1016.
102. Gillett H.R., Arnott I.D., McIntyre M., et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology. 122:2002;800-805.
103. Cellier C., Delabesse E., Helmer C., et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 356:2000;203-208.
104. Isaacson P.G. Relation between cryptic intestinal lymphoma and refractory sprue. Lancet. 356:2000;178-179.
105. Carbonnel F., Grollet-Bioul L., Brouet J.C., et al. Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood. 92:1998;3879-3886.
106. Chott A., Dragosics B., Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol. 141:1992;1361-1371.
107. Bagdi E., Diss T.C., Munson P., Isaacson P.G. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood. 94:1999;260-264.
108. Holmes G.K., Dunn G.I., Cockel R., Brookes V.S. Adenocarcinoma of the upper small bowel complicating coeliac disease. Gut. 21:1980;1010-1016.
109. Holmes G.K., Prior P., Lane M.R., Pope D., Allan R.N. Malignancy in coeliac disease-effect of a gluten free diet. Gut. 30:1989;333-338.
110. Catassi C., Fabiani E., Corrao G., et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA. 287:2002;1413-1419.
111. Swinson C.M., Slavin G., Coles E.C., Booth C.C. Coeliac disease and malignancy. Lancet. 1:1983;111-115.
112. Egan L.J., Walsh S.V., Stevens F.M., Connolly C.E., Egan E.L., McCarthy C.F. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol. 21:1995;123-129.
113. Green P.H., Jabri B. Celiac disease and other precursors to small-bowel malignancy. Gastroenterol Clin North Am. 31:2002;625-639.
114. Valdimarsson T., Toss G., Ross I., Lofman O., Strom M. Bone mineral density in coeliac disease. Scand J Gastroenterol. 29:1994;457-461.
115. Scotta M.S., Salvatore S., Salvatoni A., et al. Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol. 92:1997;1331-1334.
116. Corazza G.R., Di Sario A., Cecchetti L., et al. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone. 18:1996;525-530.
117. Fickling W.E., McFarlane X.A., Bhalla A.K., Robertson D.A. The clinical impact of metabolic bone disease in coeliac disease. Postgrad Med J. 77:2001;33-36.
118. Meyer D., Stavropolous S., Diamond B., Shane E., Green P.H. Osteoporosis in a north American adult population with celiac disease. Am J Gastroenterol. 96:2001;112-119.
119. Nuti R., Martini G., Valenti R., Giovani S., Salvadori S., Avanzati A. Prevalence of undiagnosed coeliac syndrome in osteoporotic women. J Intern Med. 250:2001;361-366.
120. Lindh E., Ljunghall S., Larsson K., Lavo B. Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med. 231:1992;403-406.
121. Sher K.S., Mayberry J.F. Female fertility, obstetric and gynaecological history in coeliac disease: a case control study. Digestion. 55:1994;243-246.
122. Ciacci C., De Rosa A., de Michele G., et al. Sexual behaviour in untreated and treated coeliac patients. Eur J Gastroenterol Hepatol. 10:1998;649-651.
123. Martinelli P., Troncone R., Paparo F., et al. Coeliac disease and unfavourable outcome of pregnancy. Gut. 46:2000;332-335.
124. Sher K.S., Mayberry J.F. Female fertility, obstetric and gynaecological history in coeliac disease: a case control study. Acta Paediatr Suppl. 412:1996;76-77.
125. Ciacci C., Cirillo M., Auriemma G., Di Dato G., Sabbatini F., Mazzacca G. Celiac disease and pregnancy outcome. Am J Gastroenterol. 91:1996;718-722.
126. Smecuol E., Maurino E., Vazquez H., et al. Gynaecological and obstetric disorders in coeliac disease: frequent clinical onset during pregnancy or the puerperium. Eur J Gastroenterol Hepatol. 8:1996;63-89.
127. Meloni G.F., Dessole S., Vargiu N., Tomasi P.A., Musumeci S. The prevalence of coeliac disease in infertility. Hum Reprod. 14:1999;2759-2761.
128. Collin P., Vilska S., Heinonen P.K., Hallstrom O., Pikkarainen P. Infertility and coeliac disease. Gut. 39:1996;382-384.
129. Kolho K.L., Tiitinen A., Tulppala M., Unkila-Kallio L., Savilahti E. Screening for coeliac disease in women with a history of recurrent miscarriage or infertility. Br J Obstet Gynaecol. 106:1999;171-173.
130. Farthing M.J., Edwards C.R., Rees L.H., Dawson A.M. Male gonadal function in coeliac disease: 1 sexual dysfunction, infertility, and semen quality. Gut. 23:1982;608-614.
131. Ludvigsson J.F., Ludvigsson J. Coeliac disease in the father affects the newborn. Gut. 49:2001;169-175.
132. Counsell C.E., Taha A., Ruddell W.S. Coeliac disease and autoimmune thyroid disease. Gut. 35:1994;844-846.
133. Iltanen S., Collin P., Korpela M., et al. Celiac disease and markers of celiac disease latency in patients with primary Sjogren's syndrome. Am J Gastroenterol. 94:1999;1042-1046.
134. O'Leary C., Walsh C.H., Wieneke P., et al. Coeliac disease and autoimmune Addison's disease: a clinical pitfall. QJM. 95:2002;79-82.
135. Dickey W., McMillan S.A., Callender M.E. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol. 25:1997;328-329.
136. Fonager K., Sorensen H.T., Norgard B., Thulstrup A.M. Cardiomyopathy in Danish patients with coeliac disease. Lancet. 354:1999;1561.
137. Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology. 117:1999;297-303.
138. Toscano V., Conti F.G., Anastasi E., et al. Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients. Am J Gastroenterol. 95:2000;1742-1748.
139. Ventura A., Neri E., Ughi C., Leopaldi A., Citta A., Not T. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr. 137:2000;263-265.
140. Chin R.L., Sander H.W., Brannagan T.H., et al. Celiac neuropathy Neurology. 60:2003;1581-1585.
141. Frustaci A., Cuoco L., Chimenti C., et al. Celiac disease associated with autoimmune myocarditis. Circulation. 105:2002;2611-2618.
142. Usai P., Cherchi M.V., Boy M.F., Cogoni G., Santa Cruz G., Balestrieri A. 2 cases of adult celiac disease simulating Berger's disease. Recenti Prog Med. 80:1989;137-139. in Italian.